EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB.
McLaughlin, G; Baumann, MH; Kavanagh, PV; Morris, N; Power, JD; Dowling, G; Twamley, B; O’Brien, J; Hessman, G; Westphal, F; Walther, D; Brandt, SD. Synthesis, analytical characterization and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta-positional isomers. Drug Test. Anal., 1 Sep 2018, 10 (9), 1404-1416. 20.6 MB. https://doi.org/10.1002/dta.2396 #4-MPM
Chapman, SJ. Novel Psychoactive Spectra: NMR of (mostly) Novel Psychoactive Substances. BLOTTER, 25 Jun 2018, 3 (2). https://doi.org/10.16889/isomerdesign-6 #4-Me-PM NMR
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV. J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #F2 LC